-
1
-
-
0014887939
-
The concept of immunological surveillance
-
Burnet FM. The concept of immunological surveillance. Prog Exp Tumor Res. 1970. 13: 1.
-
(1970)
Prog Exp Tumor Res
, vol.13
, pp. 1
-
-
Burnet, F.M.1
-
3
-
-
0030347502
-
Identification of the genes encoding cancer antigens: Implications for cancer immunotherapy
-
Rosenberg SA, Kawakami Y, Robbins PF, Wang R. Identification of the genes encoding cancer antigens: Implications for cancer immunotherapy. Adv Cancer Res. 1996. 70: 145.
-
(1996)
Adv Cancer Res
, vol.70
, pp. 145
-
-
Rosenberg, S.A.1
Kawakami, Y.2
Robbins, P.F.3
Wang, R.4
-
5
-
-
0028989965
-
Immunity to oncogenic proteins
-
Cheever MA. Disis ML, Bernhard H, Gralow JR, Hand SL, Huseby ES, Qin HL, Takahashi M, Chen W. Immunity to oncogenic proteins. Immunol Rev. 1995. 145: 33.
-
(1995)
Immunol Rev
, vol.145
, pp. 33
-
-
Cheever, M.A.1
Disis, M.L.2
Bernhard, H.3
Gralow, J.R.4
Hand, S.L.5
Huseby, E.S.6
Qin, H.L.7
Takahashi, M.8
Chen, W.9
-
6
-
-
0026074396
-
Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen
-
Chen L, Thomas EK, Hu S-L, Hellstrøm I, Hellstrøm KE. Human papillomavirus type 16 nucleoprotein E7 is a tumor rejection antigen. Proc Natl Acad Sci USA. 1991. 88: 110.
-
(1991)
Proc Natl Acad Sci USA
, vol.88
, pp. 110
-
-
Chen, L.1
Thomas, E.K.2
Hu, S.-L.3
Hellstrøm, I.4
Hellstrøm, K.E.5
-
7
-
-
0026564444
-
Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln→Leu61)
-
Gedde-Dahl III T, Spurkland A, Eriksen JA., Thorsby E, Gaudernack G. Memory T cells of a patient with follicular thyroid carcinoma recognize peptides derived from mutated p21 ras (Gln→Leu61). Int. Immunol. 1992. 4: 1331.
-
(1992)
Int. Immunol
, vol.4
, pp. 1331
-
-
Gedde-Dahl III, T.1
Spurkland, A.2
Eriksen, J.A.3
Thorsby, E.4
Gaudernack, G.5
-
8
-
-
0028057702
-
p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly→Asp)
-
Fossum B, Gedde-Dahl III T, Breivik J, Eriksen JA, Spurkland A, Thorsby E, Gaudernack G. p21-ras-peptide-specific T-cell responses in a patient with colorectal cancer. CD4+ and CD8+ T cells recognize a peptide corresponding to a common mutation (13Gly→Asp). Int J Cancer. 1994, 56: 40.
-
(1994)
Int J Cancer
, vol.56
, pp. 40
-
-
Fossum, B.1
Gedde-Dahl III, T.2
Breivik, J.3
Eriksen, J.A.4
Spurkland, A.5
Thorsby, E.6
Gaudernack, G.7
-
9
-
-
0024292722
-
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes
-
Almoguera C, Shibata D, Forrester K, Martin J, Arnheim N, Perucho M. Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. 1988. Cell. 53: 549.
-
(1988)
Cell
, vol.53
, pp. 549
-
-
Almoguera, C.1
Shibata, D.2
Forrester, K.3
Martin, J.4
Arnheim, N.5
Perucho, M.6
-
11
-
-
0028053024
-
K-ras mutation in colorectal cancer: Relations to patient age, sex and tumour location
-
Breivik J, Meling GI, Spurkland A, Rognum TO, Gaudernack G. K-ras mutation in colorectal cancer: relations to patient age, sex and tumour location. Br J Cancer. 1994. 69: 367.
-
(1994)
Br J Cancer
, vol.69
, pp. 367
-
-
Breivik, J.1
Meling, G.I.2
Spurkland, A.3
Rognum, T.O.4
Gaudernack, G.5
-
12
-
-
0024560104
-
High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis
-
Lemoine NR, Mayall ES, Wyllie FS, Williams ED, Goyns M, Stringer B, Wynford-Thomas D. High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis. Oncogene 1989. 4: 159.
-
(1989)
Oncogene
, vol.4
, pp. 159
-
-
Lemoine, N.R.1
Mayall, E.S.2
Wyllie, F.S.3
Williams, E.D.4
Goyns, M.5
Stringer, B.6
Wynford-Thomas, D.7
-
13
-
-
0026680448
-
Clinical significance of ras oncogene activation in human lung cancer
-
Rodenhuis S, Slebos RJC. Clinical significance of ras oncogene activation in human lung cancer. Cancer Res. 1992. 52: 2665.
-
(1992)
Cancer Res
, vol.52
, pp. 2665
-
-
Rodenhuis, S.1
Slebos, R.J.C.2
-
14
-
-
0029763279
-
Ki-ras point mutations and proliferation activity in biliary tract carcinomas
-
Ohashi K, Tsutsumi M, Nakajima Y, Nakano H, Konishi Y. Ki-ras point mutations and proliferation activity in biliary tract carcinomas. Br J Cancer. 1996. 74: 930.
-
(1996)
Br J Cancer
, vol.74
, pp. 930
-
-
Ohashi, K.1
Tsutsumi, M.2
Nakajima, Y.3
Nakano, H.4
Konishi, Y.5
-
15
-
-
0024438925
-
Analysis of ras oncogenes in malignant melanoma and precursor lesions: Correlation of point mutations with differentiation phenotype
-
Albino AP, Nanus DM, Mentle IR, CordonGardo C, McNutt NS, Bressler J, Andreeff M. Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene 1989. 4: 1363.
-
(1989)
Oncogene
, vol.4
, pp. 1363
-
-
Albino, A.P.1
Nanus, D.M.2
Mentle, I.R.3
Cordongardo, C.4
McNutt, N.S.5
Bressler, J.6
Andreeff, M.7
-
16
-
-
0025886953
-
Adoptive T cell therapy of tumors: Mechanisms operative in recognition and elimination of tumor cells
-
Greenberg PD. Adoptive T cell therapy of tumors: Mechanisms operative in recognition and elimination of tumor cells. Adv Immunol. 1991, 49: 281.
-
(1991)
Adv Immunol
, vol.49
, pp. 281
-
-
Greenberg, P.D.1
-
17
-
-
0025339511
-
A cell culture model for T lymphocyte clonal anergy
-
Schwartz RH, A cell culture model for T lymphocyte clonal anergy. Science 1990, 248: 1349.
-
(1990)
Science
, vol.248
, pp. 1349
-
-
Schwartz, R.H.1
-
18
-
-
0028237348
-
CD28-B7 interactions in T-cell activation
-
Allison JP. CD28-B7 interactions in T-cell activation. Curr Op Immunol. 1994, 6: 414.
-
(1994)
Curr Op Immunol
, vol.6
, pp. 414
-
-
Allison, J.P.1
-
19
-
-
0026074766
-
Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins
-
Jung S, Schluesener HJ. Human T lymphocytes recognize a peptide of single point-mutated, oncogenic ras proteins. J. Exp. Med. 1991, 73: 273.
-
(1991)
J. Exp. Med.
, vol.73
, pp. 273
-
-
Jung, S.1
Schluesener, H.J.2
-
20
-
-
0027428762
-
Overlapping epitopes encompassing a point mutation (12Gly→Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells
-
Possum B, Gedde-Dahl III T, Hansen T, Eriksen JA, Thorsby E, Gaudemack G. Overlapping epitopes encompassing a point mutation (12Gly→Arg) in p21 ras can be recognized by HLA-DR, -DP and -DQ restricted T cells. Eur J Immunol. 1993, 23: 2687.
-
(1993)
Eur J Immunol
, vol.23
, pp. 2687
-
-
Possum, B.1
Gedde-Dahl III, T.2
Hansen, T.3
Eriksen, J.A.4
Thorsby, E.5
Gaudemack, G.6
-
21
-
-
0028639458
-
Induction of human cytotoxic T cell lines directed against point-mutated p21 ras-derived synthetic peptides
-
Tsang KY, Nieroda CA, DeFilippi R, Chung YK, Yamaue H, Greiner JW, Schlom J. Induction of human cytotoxic T cell lines directed against point-mutated p21 ras-derived synthetic peptides. Vaccine Res. 1994, 3: 183.
-
(1994)
Vaccine Res
, vol.3
, pp. 183
-
-
Tsang, K.Y.1
Nieroda, C.A.2
Defilippi, R.3
Chung, Y.K.4
Yamaue, H.5
Greiner, J.W.6
Schlom, J.7
-
22
-
-
0029043003
-
CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients
-
Qin H, Chen W, Takahashi M, Disis ML, Byrd DR, Me Cahill L, Bertram KA, Fenton RG, Peace DJ, Cheever MA. CD4+ T-cell immunity to mutated ras protein in pancreatic and colon cancer patients. Cancer Res. 1995. 55: 2984.
-
(1995)
Cancer Res
, vol.55
, pp. 2984
-
-
Qin, H.1
Chen, W.2
Takahashi, M.3
Disis, M.L.4
Byrd, D.R.5
Me Cahill, L.6
Bertram, K.A.7
Fenton, R.G.8
Peace, D.J.9
Cheever, M.A.10
-
23
-
-
0028924505
-
Induction and characterization of cytotoxic T lymphocytes recognizing a mutated p21 ras peptide presented by HLA-A*0201
-
Van Elsas A, Nijman HW, Van der Minne CE, Mourer JS, Kast WM, Melief CJM, Schrier PI. Induction and characterization of cytotoxic T lymphocytes recognizing a mutated p21 ras peptide presented by HLA-A*0201. Int J Cancer. 1995, 61: 389.
-
(1995)
Int J Cancer
, vol.61
, pp. 389
-
-
Van Elsas, A.1
Nijman, H.W.2
Van der Minne, C.E.3
Mourer, J.S.4
Kast, W.M.5
Melief, C.J.M.6
Schrier, P.I.7
-
24
-
-
0028153777
-
Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras
-
Gedde-Dahl III T, Nilsen E, Thorsby E, Gaudernack G. Growth inhibition of a colonic adenocarcinoma cell line (HT29) by T cells specific for mutant p21 ras. Cancer Immunol Immunother. 1994b, 38: 127.
-
(1994)
Cancer Immunol Immunother
, vol.38
, pp. 127
-
-
Gedde-Dahl III, T.1
Nilsen, E.2
Thorsby, E.3
Gaudernack, G.4
-
25
-
-
0028934910
-
CD8+ T cells from a patient with colon carcinoma, specific for a mutant p21 ras derived peptide (13Gly→Asp), are cytotoxic towards a carcinoma cell line harbouring the same mutation
-
Possum B, Olsen AC, Thorsby E, Gaudernack, G. CD8+ T cells from a patient with colon carcinoma, specific for a mutant p21 ras derived peptide (13Gly→Asp), are cytotoxic towards a carcinoma cell line harbouring the same mutation. Cancer Immunol. Immunother. 1995, 40: 165.
-
(1995)
Cancer Immunol. Immunother.
, vol.40
, pp. 165
-
-
Possum, B.1
Olsen, A.C.2
Thorsby, E.3
Gaudernack, G.4
-
26
-
-
0028856743
-
Vaccination with mutant ras peptides and induction of T cell responsiveness in pancreatic-carcinoma patients after mutant ras peptide vaccination
-
Gjertsen MK, Bakka A, Breivik J, Saeterdal I, Solheim BG, Sereide O, Thorsby E,Gaudemack G: Vaccination with mutant ras peptides and induction of T cell responsiveness in pancreatic-carcinoma patients after mutant ras peptide vaccination. Lancet 1995;346:1399-1400.
-
(1995)
Lancet
, vol.346
, pp. 1399-1400
-
-
Gjertsen, M.K.1
Bakka, A.2
Breivik, J.3
Saeterdal, I.4
Solheim, B.G.5
Sereide, O.6
Thorsby, E.7
Gaudemack, G.8
-
27
-
-
13344270400
-
Ex-vivo ras peptide vaccination in patients with advanced pancreatic cancer: Results of a phase-I/II study
-
Gjertsen MK, Bakka A, Breivik J, Sasterdal I, Gedde-Dahl III T, Stokke KT, Solheim BG, Egge TS, Søreide O, Thorsby E, GaudernackG: Ex-vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase-I/II study. Int J Cancer 1996a;65:450-453.
-
(1996)
Int J Cancer
, vol.65
, pp. 450-453
-
-
Gjertsen, M.K.1
Bakka, A.2
Breivik, J.3
Sasterdal, I.4
Gedde-Dahl III, T.5
Stokke, K.T.6
Solheim, B.G.7
Egge, T.S.8
Søreide, O.9
Thorsby, E.10
Gaudernack, G.11
-
28
-
-
0030026776
-
Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells
-
Hsu FJ, Benike C, Fagnoni F, Lues TM, Czerwinski D, Taidi B, Engleman EG, Levy R. Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells. 1996. Nat Med. 2(1): 52.
-
(1996)
Nat Med
, vol.2
, Issue.1
, pp. 52
-
-
Hsu, F.J.1
Benike, C.2
Fagnoni, F.3
Lues, T.M.4
Czerwinski, D.5
Taidi, B.6
Engleman, E.G.7
Levy, R.8
-
29
-
-
0030858138
-
Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells
-
Cella M, Engering A, Pinet V, Pieters J, Lanzavecchia A. Inflammatory stimuli induce accumulation of MHC class II complexes on dendritic cells. Nature 1997;388(6644):782-787.
-
(1997)
Nature
, vol.388
, Issue.6644
, pp. 782-787
-
-
Cella, M.1
Engering, A.2
Pinet, V.3
Pieters, J.4
Lanzavecchia, A.5
-
30
-
-
0025735629
-
The dendritic cell system and its role in immunogenicity
-
Steinmann RM. The dendritic cell system and its role in immunogenicity. Ann Rev Immunol. 1991;9:271-296.
-
(1991)
Ann Rev Immunol
, vol.9
, pp. 271-296
-
-
Steinmann, R.M.1
-
31
-
-
0028137762
-
T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA
-
Gedde-Dahl III T, Spurkland A, Possum B, Wittinghofer A, Thorsby E, Gaudernack G. T cell epitopes encompassing the mutational hot spot position 61 of p21 ras. Promiscuity in ras peptide binding to HLA. Eur J Immunol. 1994a. 24: 410.
-
(1994)
Eur J Immunol.
, vol.24
, pp. 410
-
-
Gedde-Dahl III, T.1
Spurkland, A.2
Possum, B.3
Wittinghofer, A.4
Thorsby, E.5
Gaudernack, G.6
-
32
-
-
0028234535
-
Binding of ras oncogene peptides to purified HLA-DQ (alpha 1*0102,beta 1*0602) molecules
-
Johansen BH, Gedde-Dahl III T, Sollid LM, Vartdal F, Thorsby E, Gaudemack G. Binding of ras oncogene peptides to purified HLA-DQ (alpha 1*0102,beta 1*0602) molecules. Scand J Immunol. 1994. 39: 607.
-
(1994)
Scand J Immunol
, vol.39
, pp. 607
-
-
Johansen, B.H.1
Gedde-Dahl III, T.2
Sollid, L.M.3
Vartdal, F.4
Thorsby, E.5
Gaudemack, G.6
-
33
-
-
0029825827
-
Characterisation of immune responses in pancreatic carcinoma patients after mutant-p21-ras peptide vaccination
-
Gjertsen MK, Sæterdal I, Thorsby E, Gaudernack G. Characterisation of immune responses in pancreatic carcinoma patients after mutant-p21-ras peptide vaccination. Brit J Cancer. 1996;74:1828-1833.
-
(1996)
Brit J Cancer
, vol.74
, pp. 1828-1833
-
-
Gjertsen, M.K.1
Sæterdal, I.2
Thorsby, E.3
Gaudernack, G.4
-
34
-
-
0026042333
-
Sequence analysis of peptides bound to MHC-class II molecules
-
Rudensky AY, Preston-Hurlburt P, Hong SC, Barlow A, Janeway Jr CA. Sequence analysis of peptides bound to MHC-class II molecules. Nature 1991;353:622-627.
-
(1991)
Nature
, vol.353
, pp. 622-627
-
-
Rudensky, A.Y.1
Preston-Hurlburt, P.2
Hong, S.C.3
Barlow, A.4
Janeway Jr., C.A.5
-
35
-
-
0026664454
-
d
-
d. Science 1992;256:1817.
-
(1992)
Science
, vol.256
, pp. 1817
-
-
Hunt, D.F.1
Michel, H.2
Dickinson, T.A.3
Schabonowitz, J.4
Cox, A.L.5
Sakaguchi, K.6
Appella, E.7
Grey, H.M.8
Sette, A.9
-
36
-
-
0026733449
-
Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogenous in size
-
Chicz RM, Urban RG, Lane WS, Gorga JC, Stern LJ, Vignali DAA, Strominger JL. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogenous in size. Nature 1992. 358: 764.
-
(1992)
Nature
, vol.358
, pp. 764
-
-
Chicz, R.M.1
Urban, R.G.2
Lane, W.S.3
Gorga, J.C.4
Stern, L.J.5
Vignali, D.A.A.6
Strominger, J.L.7
-
37
-
-
0030749292
-
Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12-Val dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation
-
Gjertsen MK, Bjørheim J, Sæterdal I, Myklebust J, Gaudernack G. Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12-Val dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation. Int J Cancer 1997;72:784-790.
-
(1997)
Int J Cancer
, vol.72
, pp. 784-790
-
-
Gjertsen, M.K.1
Bjørheim, J.2
Sæterdal, I.3
Myklebust, J.4
Gaudernack, G.5
-
38
-
-
0026555250
-
Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide
-
Carreno BM, Turner RV, Biddison WE, Coligan JE. Overlapping epitopes that are recognized by CD8+ HLA class I-restricted and CD4+ class II-restricted cytotoxic T lymphocytes are contained within an influenza nucleoprotein peptide. J Immunol. 1992. 148: 894.
-
(1992)
J Immunol
, vol.148
, pp. 894
-
-
Carreno, B.M.1
Turner, R.V.2
Biddison, W.E.3
Coligan, J.E.4
-
39
-
-
0024410347
-
Identical peptides recognized by MHC class I-and class II-restricted T cells
-
Perkins DL, Lai M-Z, Smith JA, Gefter ML. Identical peptides recognized by MHC class I-and class II-restricted T cells. J. Exp. Med. 1989. 170: 279.
-
(1989)
J. Exp. Med.
, vol.170
, pp. 279
-
-
Perkins, D.L.1
Lai, M.-Z.2
Smith, J.A.3
Gefter, M.L.4
-
40
-
-
0025022393
-
An immuno-dominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type I induces CD4 class II-restricted help for itself
-
Takahashi H, Germain RN, Moss B, et al. An immuno-dominant class I-restricted cytotoxic T lymphocyte determinant of human immunodeficiency virus type I induces CD4 class II-restricted help for itself. J Exp Med. 1990. 171: 571.
-
(1990)
J Exp Med
, vol.171
, pp. 571
-
-
Takahashi, H.1
Germain, R.N.2
Moss, B.3
-
41
-
-
0028281585
-
Interleukin 12: A key modulator of immune function
-
Wolf SF, Sieburth D, Sypek J. Interleukin 12: a key modulator of immune function. Stem Cells Dayt. 1994. 12 (2): 154.
-
(1994)
Stem Cells Dayt
, vol.12
, Issue.2
, pp. 154
-
-
Wolf, S.F.1
Sieburth, D.2
Sypek, J.3
-
42
-
-
0028820386
-
Reconstitution of cellular immunity against CMV in recipients of allogeneic bone marrow by adoptive transfer of T cell clones from the donor
-
Walter, E. A., Greenberg, P. D., Gilbert, M. J., Finch, R. J., Watanabe, K. S., Thomas, E. D. and Riddell, S. R. Reconstitution of cellular immunity against CMV in recipients of allogeneic bone marrow by adoptive transfer of T cell clones from the donor. N Engl J Med. 1995. 333: 1038.
-
(1995)
N Engl J Med
, vol.333
, pp. 1038
-
-
Walter, E.A.1
Greenberg, P.D.2
Gilbert, M.J.3
Finch, R.J.4
Watanabe, K.S.5
Thomas, E.D.6
Riddell, S.R.7
-
43
-
-
0029143544
-
Petide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21
-
Abrams SI, Dobrzanski MJ, Wells DT, Stanziale SF, Zaremba S, Masuelle L, Kantor JA, Schlom J. Petide-specific activation of cytolytic CD4+ T lymphocytes against tumor cells bearing mutated epitopes of K-ras p21. Eur J Immunol. 1995. 25: 2588.
-
(1995)
Eur J Immunol
, vol.25
, pp. 2588
-
-
Abrams, S.I.1
Dobrzanski, M.J.2
Wells, D.T.3
Stanziale, S.F.4
Zaremba, S.5
Masuelle, L.6
Kantor, J.A.7
Schlom, J.8
-
44
-
-
0030027269
-
Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses
-
Abrams SI, Stanziale SF, Lunin SD, Zaremba S, Schlom J. Identification of overlapping epitopes in mutant ras oncogene peptides that activate CD4+ and CD8+ T cell responses. Eur J Immunol. 1996. 26: 435.
-
(1996)
Eur J Immunol
, vol.26
, pp. 435
-
-
Abrams, S.I.1
Stanziale, S.F.2
Lunin, S.D.3
Zaremba, S.4
Schlom, J.5
-
45
-
-
0029997742
-
Generation of cytotoxic T-cell responses with synthetic melanoma associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens
-
Jäger E, Bernhard H, Romero P, Ringhoffer M, Arand M, Karbach J, Ilsemann C, Hagedorn M, Knuth A, Generation of cytotoxic T-cell responses with synthetic melanoma associated peptides in vivo: Implications for tumor vaccines with melanoma-associated antigens. Int J Cancer. 1966. 66: 162.
-
(1966)
Int J Cancer
, vol.66
, pp. 162
-
-
Jäger, E.1
Bernhard, H.2
Romero, P.3
Ringhoffer, M.4
Arand, M.5
Karbach, J.6
Ilsemann, C.7
Hagedorn, M.8
Knuth, A.9
-
46
-
-
0041485051
-
Granulocyte-macrophage colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo
-
Jäger E, Ringhoffer M, Dienes HP, Arand M, Karbach J, Jäger D, Ilsemann C, Hagedorn M, Oesch F, Knuth A. Granulocyte-macrophage colony-stimulating factor enhances immune responses to melanoma-associated peptides in vivo. Int J Cancer. 1996c. 67: 54.
-
(1996)
Int J Cancer
, vol.67
, pp. 54
-
-
Jäger, E.1
Ringhoffer, M.2
Dienes, H.P.3
Arand, M.4
Karbach, J.5
Jäger, D.6
Ilsemann, C.7
Hagedorn, M.8
Oesch, F.9
Knuth, A.10
-
47
-
-
0029987485
-
Granulocyte-macrophage colony-stimulating factor: An effective adjuvant for protein and peptide-based vaccines
-
Disis ML, Bernhard H, Shiota FM et al. Granulocyte-macrophage colony-stimulating factor: An effective adjuvant for protein and peptide-based vaccines. Blood 1996. 88: 202.
-
(1996)
Blood
, vol.88
, pp. 202
-
-
Disis, M.L.1
Bernhard, H.2
Shiota, F.M.3
-
48
-
-
0030000146
-
Inverse relationship of melanocyte-differentiation antigen expression in melanoma: Evidence for immunoselection of antigen-loss variants in vivo
-
Jäger E, Ringhoffer M, Karbach J, Arand M, Oesch F, Knuth A. Inverse relationship of melanocyte-differentiation antigen expression in melanoma: Evidence for immunoselection of antigen-loss variants in vivo. Int J Cancer. 1996. 66: 470.
-
(1996)
Int J Cancer
, vol.66
, pp. 470
-
-
Jäger, E.1
Ringhoffer, M.2
Karbach, J.3
Arand, M.4
Oesch, F.5
Knuth, A.6
-
49
-
-
0029840729
-
Detection of ras gene mutations in perioperative peripheral blood with pancreatic adenocarcinoma
-
Nomoto S, Nakao A, Kasai Y, Harada A, Nonami T, Takagi H. Detection of ras gene mutations in perioperative peripheral blood with pancreatic adenocarcinoma. Jpn J Cancer Res 1996;87:793-797.
-
(1996)
Jpn J Cancer Res
, vol.87
, pp. 793-797
-
-
Nomoto, S.1
Nakao, A.2
Kasai, Y.3
Harada, A.4
Nonami, T.5
Takagi, H.6
|